caa a22 4500 469026677 CHVBK 20180323132731.0 cr unu---uuuuu 170328e19921001xx s 000 0 eng 10.1007/BF01977619 doi (NATIONALLICENCE)springer-10.1007/BF01977619 A drug use review study in patients with obstructive lung disease [Elektronische Daten] Assessment of the quality of drug therapy [G. Van den Brink, C. Bollen, O. Van de Wall, L. Hoeve, A. Porsius] This study presents the results of an analysis of the pharmacy records of 778 patients with asthma or chronic obstructive lung diseases. The high percentage of patients taking oral corticosteroids was striking. Inhaledβ-agonists for use as needed have been prescribed to only a minority of patients using these agents. Only half of the patients onβ-agonists used inhaled corticosteroids prophylactically. Drug interactions capable of causing changes in plasma theophylline concentrations appeared in only a small number of patients. The results from studies like the one presented here can provide valuable data to be used for further discussion between physicians and pharmacists about rational drug therapy. Royal Dutch Association for Advancement of Pharmacy, 1992 Adrenal cortex hormones nationallicence Adrenergic beta receptor agonists nationallicence Adrenergic beta receptor blockaders nationallicence Contra-indications nationallicence Dosage regimens nationallicence Drug interactions nationallicence Drug therapy nationallicence Drug utilization nationallicence Lung diseases, obstructive nationallicence Quality control nationallicence Van den Brink G. Department of Pharmacotherapy, University of Utrecht, P.O. Box 80.082, 3508, TB Utrecht, The Netherlands aut Bollen C. Department of Pharmacotherapy, University of Utrecht, P.O. Box 80.082, 3508, TB Utrecht, The Netherlands aut Van de Wall O. Department of Pharmacotherapy, University of Utrecht, P.O. Box 80.082, 3508, TB Utrecht, The Netherlands aut Hoeve L. Health Fund Pharmacy "Ziekenzorg,”, Catharijnesingel 57, 3511, GH Utrecht, The Netherlands aut Porsius A. Department of Pharmacotherapy, University of Utrecht, P.O. Box 80.082, 3508, TB Utrecht, The Netherlands aut Pharmaceutisch Weekblad Kluwer Academic Publishers 14/5(1992-10-01), 311-315 0031-6911 14:5<311 1992 14 11096 https://doi.org/10.1007/BF01977619 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF01977619 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Van den Brink G. Department of Pharmacotherapy, University of Utrecht, P.O. Box 80.082, 3508, TB Utrecht, The Netherlands aut NATIONALLICENCE 700 1- Bollen C. Department of Pharmacotherapy, University of Utrecht, P.O. Box 80.082, 3508, TB Utrecht, The Netherlands aut NATIONALLICENCE 700 1- Van de Wall O. Department of Pharmacotherapy, University of Utrecht, P.O. Box 80.082, 3508, TB Utrecht, The Netherlands aut NATIONALLICENCE 700 1- Hoeve L. Health Fund Pharmacy "Ziekenzorg,”, Catharijnesingel 57, 3511, GH Utrecht, The Netherlands aut NATIONALLICENCE 700 1- Porsius A. Department of Pharmacotherapy, University of Utrecht, P.O. Box 80.082, 3508, TB Utrecht, The Netherlands aut NATIONALLICENCE 773 0- Pharmaceutisch Weekblad Kluwer Academic Publishers 14/5(1992-10-01), 311-315 0031-6911 14:5<311 1992 14 11096 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer